A 3D co-culture of three human cell lines to model the inflamed intestinal mucosa for safety testing of nanomaterials

Nanotoxicology

Volumn 10, Issue 1, 2016, Pages 53-62

  Susewind, Julia ^a   De Souza Carvalho Wodarz, Cristiane ^a   Repnik, Urska ^c   Collnot, Eva Maria ^a,b   Schneider Daum, Nicole ^a   Griffiths, Gareth Wyn ^c   Lehr, Claus Michael ^a,b  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Caco 2; cytotoxicity; intestine; nanoparticles

Indexed keywords

COLLAGEN; GOLD NANOPARTICLE; INTERLEUKIN 1BETA; INTERLEUKIN 8; MESSENGER RNA; SILVER NANOPARTICLE; TITANIUM DIOXIDE NANOPARTICLE; METAL NANOPARTICLE; NANOMATERIAL; TITANIUM; TITANIUM DIOXIDE;

ARTICLE; CACO 2 CELL LINE; CELL ULTRASTRUCTURE; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DRUG CYTOTOXICITY; ENTERITIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE MUCOSA; MACROPHAGE CULTURE; MONOCULTURE; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THREE DIMENSIONAL IMAGING; TIGHT JUNCTION; TRANSEPITHELIAL RESISTANCE; BIOSYNTHESIS; CACO-2 CELL LINE; CHEMICALLY INDUCED; DRUG EFFECTS; INFLAMMATION;

CACO-2 CELLS; COCULTURE TECHNIQUES; HUMANS; INFLAMMATION; INTERLEUKIN-8; INTESTINAL MUCOSA; METAL NANOPARTICLES; NANOSTRUCTURES; TITANIUM;

EID: 84959544878     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2015.1008065     Document Type: Article

References (58)

1. Alexis NE, Huang YC, Rappold AG, Kehrl H, Devlin R, Peden DB. 2014. Patients with asthma demonstrate airway inflammation after exposure to concentrated ambient particulate matter. Am J Respir Crit Care Med 190:235-7.
2. Alfaro-Moreno E, Nawrot TS, Vanaudenaerde BM, Hoylaerts MF, Vanoirbeek JA, Nemery B, Hoet PH. 2008. Co-cultures of multiple cell types mimic pulmonary cell communication in response to urban PM10. Eur Respir J 32:1184-94.
3. Arora S, Rajwade JM, Paknikar KM. 2012. Nanotoxicology and in vitro studies: the need of the hour. Toxicol Appl Pharmacol 258:151-65.
4. Ayala V, Herrera AP, Latorre-Esteves M, Torres-Lugo M, Rinaldi C. 2013. Effect of surface charge on the colloidal stability and in vitro uptake of carboxymethyl dextran-coated iron oxide nanoparticles. J Nanopart Res 15:1874.
5. Beer C, Foldbjerg R, Hayashi Y, Sutherland DS, Autrup H. 2012. Toxicity of silver nanoparticles-nanoparticle or silver ion? Toxicol Lett 208: 286-92.
6. Beloqui A, Coco R, Memvanga PB, Ucakar B, des Rieux A, Preat V. 2014. pH-Sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease. Int J Pharm 473:203-12.
7. Bertiaux-Vandaele N, Youmba SB, Belmonte L, Lecleire S, Antonietti M, Gourcerol G, et al. 2011. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype. Am J Gastroenterol 106:2165-73.
8. Bisping G, Lugering N, Lutke-Brintrup S, Pauels HG, Schurmann G, Domschke W, Kucharzik T. 2001. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes cocultured with intestinal epithelial cells. Clin Exp Immunol 123:15-22.
9. Bodet C, Chandad F, Grenier D. 2006. Inflammatory responses of a macrophage/epithelial cell co-culture model to mono and mixed infections with Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia. Microbes Infect 8:27-35.
10. Cho WS, Kim S, Han BS, Son WC, Jeong J. 2009. Comparison of gene expression profiles in mice liver following intravenous injection of 4 and 100 nm-sized PEG-coated gold nanoparticles. Toxicol Lett 191: 96-102.
11. Desjardins M, Griffiths G. 2003. Phagocytosis: latex leads the way. Curr Opin Cell Biol 15:498-503.
12. Dobrovolskaia MA, Aggarwal P, Hall JB, McNeil SE. 2008. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm 5: 487-95.
13. Dobrovolskaia MA, McNeil SE. 2007. Immunological properties of engineered nanomaterials. Nat Nanotechnol 2:469-78.
14. Fang HW, Fang SB, Chiang Chiau JS, Yeung CY, Chan WT, Jiang CB, et al. 2010. Inhibitory effects of Lactobacillus casei subsp. rhamnosus on Salmonella lipopolysaccharide-induced inflammation and epithelial barrier dysfunction in a co-culture model using Caco-2/peripheral blood mononuclear cells. J Med Microbiol 59:573-9.
15. Fisichella M, Berenguer F, Steinmetz G, Auffan M, Rose J, Prat O. 2012. Intestinal toxicity evaluation of TiO2 degraded surface-treated nanoparticles: a combined physico-chemical and toxicogenomics approach in caco-2 cells. Part Fibre Toxicol 9:18.
16. Foger F, Kopf A, Loretz B, Albrecht K, Bernkop-Schnurch A. 2008. Correlation of in vitro and in vivo models for the oral absorption of peptide drugs. Amino Acids 35:233-41.
17. Frick A, Moller H, Wirbitzki E. 1998. Biopharmaceutical characterization of oral immediate release drug products. In vitro/in vivo comparison of phenoxymethylpenicillin potassium, glimepiride and levofloxacin. Eur J Pharm Biopharm 46:305-11.
18. Frohlich E, Roblegg E. 2012. Models for oral uptake of nanoparticles in consumer products. Toxicology 291:10-17.
19. Gaiser BK, Fernandes TF, Jepson M, Lead JR, Tyler CR, Stone V. 2009. Assessing exposure, uptake and toxicity of silver and cerium dioxide nanoparticles from contaminated environments. Environ Health 8:S2.
20. Gaiser BK, Fernandes TF, Jepson MA, Lead JR, Tyler CR, Baalousha M, et al. 2012. Interspecies comparisons on the uptake and toxicity of silver and cerium dioxide nanoparticles. Environ Toxicol Chem 31: 144-54.
21. Gaiser BK, Hirn S, Kermanizadeh A, Kanase N, Fytianos K, Wenk A, et al. 2013. Effects of silver nanoparticles on the liver and hepatocytes in vitro. Toxicol Sci 131:537-47.
22. Guo S, Al-Sadi R, Said HM, Ma TY. 2013. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am J Pathol 182:375-87.
23. Hermanns MI, Kasper J, Dubruel P, Pohl C, Uboldi C, Vermeersch V, et al. 2010. An impaired alveolar-capillary barrier in vitro: effect of proinflammatory cytokines and consequences on nanocarrier interaction. J R Soc Interface 7:S41-54.
24. Hsiao IL, Huang YJ. 2011. Effects of various physicochemical characteristics on the toxicities of ZnO and TiO nanoparticles toward human lung epithelial cells. Sci Total Environ 409:1219-28.
25. Kasper J, Hermanns MI, Bantz C, Maskos M, Stauber R, Pohl C, Unger RE, Kirkpatrick JC. 2011. Inflammatory and cytotoxic responses of an alveolar-capillary coculture model to silica nanoparticles: comparison with conventional monocultures. Part Fibre Toxicol 8:6.
26. Kermanizadeh A, Pojana G, Gaiser BK, Birkedal R, Bilanicova D, Wallin H, et al. 2013a. In vitro assessment of engineered nanomaterials using a hepatocyte cell line: cytotoxicity, pro-inflammatory cytokines and functional markers. Nanotoxicology 7:301-13.
27. Kermanizadeh A, Vranic S, Boland S, Moreau K, Baeza-Squiban A, Gaiser BK, Andrzejczuk LA, Stone V. 2013b. An in vitro assessment of panel of engineered nanomaterials using a human renal cell line: cytotoxicity, pro-inflammatory response, oxidative stress and genotoxicity. BMC Nephrol 14:96.
28. Kish L, Hotte N, Kaplan GG, Vincent R, Tso R, Ganzle M, et al. 2013. Environmental particulate matter induces murine intestinal inflammatory responses and alters the gut microbiome. PLoS One 8:e62220.
29. Koeneman BA, Zhang Y, Westerhoff P, Chen Y, Crittenden JC, Capco DG. 2010. Toxicity and cellular responses of intestinal cells exposed to titanium dioxide. Cell Biol Toxicol 26:225-38.
30. Kuhlbusch TA, Asbach C, Fissan H, Gohler D, Stintz M. 2011. Nanoparticle exposure at nanotechnology workplaces: a review. Part Fibre Toxicol 8:22.
31. Lee YJ, Kim J, Oh J, Bae S, Lee S, Hong IS, Kim SH. 2012. Ion-release kinetics and ecotoxicity effects of silver nanoparticles. Environ Toxicol Chem 31:155-9.
32. Lefebvre DE, Venema K, Gombau L, Valerio Jr LG, Raju J, Bondy GS, et al. 2014. Utility of models of the gastrointestinal tract for assessment of the digestion and absorption of engineered nanomaterials released from food matrices. Nanotoxicology [Epub ahead of print]. doi:10.3109/17435390.2014.948091.
33. Lehmann AD, Blank F, Baum O, Gehr P, Rothen-Rutishauser BM. 2009. Diesel exhaust particles modulate the tight junction protein occludin in lung cells in vitro. Part Fibre Toxicol 6:26.
34. Lehmann AD, Parak WJ, Zhang F, Ali Z, Rocker C, Nienhaus GU, et al. 2010. Fluorescent-magnetic hybrid nanoparticles induce a dosedependent increase in proinflammatory response in lung cells in vitro correlated with intracellular localization. Small 6:753-62.
35. Leonard F, Ali H, Collnot EM, Crielaard BJ, Lammers T, Storm G, Lehr CM. 2012. Screening of budesonide nanoformulations for treatment of inflammatory bowel disease in an inflamed 3D cell-culture model. ALTEX 29:275-85.
36. Leonard F, Collnot EM, Lehr CM. 2010. A three-dimensional coculture of enterocytes, monocytes and dendritic cells to model inflamed intestinal mucosa in vitro. Mol Pharm 7:2103-19.
37. Loeschner K, Hadrup N, Qvortrup K, Larsen A, Gao X, Vogel U, et al. 2011. Distribution of silver in rats following 28 days of repeated ora exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol 8:18.
38. Mahmud N, Weir DG. 2001. The urban diet and Crohn's disease: is there a relationship?' Eur J Gastroenterol Hepatol 13:93-5.
39. Mironava T, Hadjiargyrou M, Simon M, Jurukovski V, Rafailovich MH. 2010. Gold nanoparticles cellular toxicity and recovery: effect of size, concentration and exposure time. Nanotoxicology 4:120-37.
40. Muller L, Riediker M, Wick P, Mohr M, Gehr P, Rothen-Rutishauser B. 2010. Oxidative stress and inflammation response after nanoparticle exposure: differences between human lung cell monocultures and an advanced three-dimensional model of the human epithelial airways. J R Soc Interface 7:S27-40.
41. Muzes G, Molnar B, Tulassay Z, Sipos F. 2012. Changes of the cytokine profile in inflammatory bowel diseases. World J Gastroenterol 18: 5848-61.
42. Newton KM, Puppala HL, Kitchens CL, Colvin VL, Klaine SJ. 2013. Silver nanoparticle toxicity to Daphnia magna is a function of dissolved silver concentration. Environ Toxicol Chem 32:2356-64.
43. Perreault F, Melegari SP, Fuzinatto CF, Bogdan N, Morin M, Popovic R, Matias WG. 2012. Toxicity of PAMAM-coated gold nanoparticles in different unicellular models. Environ Toxicol 29: 328-36.
44. Powell JJ, Faria N, Thomas-McKay E, Pele LC. 2010. Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. J Autoimmun 34:J226-33.
45. Rothen-Rutishauser B, Mueller L, Blank F, Brandenberger C, Muehlfeld C, Gehr P. 2008. A newly developed in vitro model of the human epithelial airway barrier to study the toxic potential of nanoparticles. ALTEX 25:191-6.
46. Rothen-Rutishauser B, Muhlfeld C, Blank F, Musso C, Geh P. 2007. Translocation of particles and inflammatory responses after exposure to fine particles and nanoparticles in an epithelial airway model. Part Fibre Toxicol 4:9.
47. Rothen-Rutishauser BM, Kiama SG, Gehr P. 2005. A three-dimensional cellular model of the human respiratory tract to study the interaction with particles. Am J Respir Cell Mol Biol 32:281-9.
48. Satsu H, Ishimoto Y, Nakano T, Mochizuki T, Iwanaga T, Shimizu M. 2006. Induction by activated macrophage-like THP-1 cells of apoptotic and necrotic cell death in intestinal epithelial Caco-2 monolayers via tumor necrosis factor-alpha. Exp Cell Res 312:3909-19.
49. Schimpel C, Teubl B, Absenger M, Meindl C, Frohlich E, Leitinger G, et al. 2014. Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles. Mol Pharm 11:808-18.
50. Schulzke JD, Ploeger S, Amasheh M, Fromm A, Zeissig S, Troeger H, et al. 2009. Epithelial tight junctions in intestinal inflammation. Ann N Y Acad Sci 1165:294-300.
51. Sung JH, Ji JH, Park JD, Song MY, Song KS, Ryu HR, et al. 2011. Subchronic inhalation toxicity of gold nanoparticles. Part Fibre Toxicol 8:6.
52. Theegarten D, Boukercha S, Philippou S, Anhenn O. 2010. Submesothelial deposition of carbon nanoparticles after toner exposition: case report. Diagn Pathol 5:77.
53. Ucciferri N, Collnot EM, Gaiser BK, Tirella A, Stone V, Domenici C, et al. 2014. In vitro toxicological screening of nanoparticles on primary human endothelial cells and the role of flow in modulating cell response. Nanotoxicology 8:697-708.
54. Walter E, Janich S, Roessler BJ, Hilfinger JM, Amidon GL. 1996. HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans. J Pharm Sci 85:1070-6.
55. Weir A, Westerhoff P, Fabricius L, Hristovski K, von Goetz N. 2012. Titanium dioxide nanoparticles in food and personal care products. Environ Sci Technol 46:2242-50.
56. Zeissig S, Burgel N, Gunzel D, Richter J, Mankertz J, Wahnschaffe U, et al. 2007. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 56:61-72.
57. Zhang J, Song W, Guo J, Sun Z, Li L, Ding F, Gao M. 2012. Cytotoxicity of different sized TiO2 nanoparticles in mouse macrophages. Toxicol Ind Health 29:523-33.
58. Zhang XD, Wu D, Shen X, Liu PX, Yang N, Zhao B, et al. 2011. Sizedependent in vivo toxicity of PEG-coated gold nanoparticles. Int J Nanomedicine 6:2071-81.